Source link : https://www.newshealth.biz/health-news/novel-tx-also-cuts-bleeding-in-kids/
Efanesoctocog alfa, a first-in-class, bioengineered human factor VIII replacement therapy, shows safety and efficacy in the prevention of bleeding in children with severe hemophilia A, with benefits similar to those observed in adults, new research shows. “In this study, once-weekly efanesoctocog alfa provided high sustained factor VIII activity and highly efficacious protection against bleeding episodes […]
Author : News Health
Publish date : 2024-07-23 12:45:18
Copyright for syndicated content belongs to the linked Source.
Categories